Jump to content


Welcome to Sclero Forums!! How may we help you?


Photo

The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease.

biologics

  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,716 posts
  • Location:West Sussex

Posted 17 July 2014 - 10:02 AM

The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease.

 

In multi-system autoimmune disease, prior cyclophosphamide exposure and glucocorticoid therapy but not cumulative rituximab dose was associated with an increased incidence of hypogammaglobulinaemia and repeat dose rituximab therapy appears safe with judicious monitoring. PubMed, BMC Musculoskelet Disord, 2014 May 25;15(1):178. (Also see: Mainstream Treatments: Biologics)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde
ISN Assistant Webmaster
SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager
ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)